Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 15, 2016

T. ROWE PRICE GROWTH STOCK FUND, INC. et al v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC., et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 31, 2017

    T. Rowe, Funds Fight Valeant's Bid To Kill Stock Drop Suits

    T. Rowe Price Group Inc. and other investors asked a New Jersey federal court on Friday not to dismiss their securities suits against Valeant Pharmaceuticals International Inc., saying Valeant and its executives have rehashed the same arguments that the court rejected in a similar case.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login